Free Trial
CVE:THCX

Hydropothecary (THCX) Stock Price, News & Analysis

Hydropothecary logo
C$5.30 +0.33 (+6.64%)
As of 06/21/2018

About Hydropothecary Stock (CVE:THCX)

Key Stats

Today's Range
C$5.00
C$5.37
50-Day Range
C$5.30
C$5.30
52-Week Range
C$1.10
C$5.42
Volume
5.38 million shs
Average Volume
2.35 million shs
Market Capitalization
C$949.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

The Hydropothecary Corporation, together with its subsidiaries, produces and distributes medical marijuana products. The company is headquartered in Gatineau, Canada.

Receive THCX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hydropothecary and its competitors with MarketBeat's FREE daily newsletter.

THCX Stock News Headlines

AXS CANNABIS ETF ESTIMATED CASH (^THCX-EU)
The Hydropothecary Corporation (HEXO.TO)
Warning: Massive IPO Predicted for May 14?
The #1 venture capitalist in America predicts that the biggest IPO in history will take place on Wednesday, May 14. And as Fortune has written, this IPO is “larger than any IPO valuation in history”…
AXS Cannabis ETF (THCX)
Optimum Investment Advisors Bu - GuruFocus.com
See More Headlines

THCX Stock Analysis - Frequently Asked Questions

Hydropothecary's stock was trading at C$5.30 on January 1st, 2025. Since then, THCX stock has increased by 0.0% and is now trading at C$5.30.
View the best growth stocks for 2025 here
.

Shares of THCX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Hydropothecary investors own include Canopy Growth (WEED), Aurora Cannabis (ACB), Aphria (APHA), Canopy Growth (CGC), Cronos Group (CRON), CannTrust (CTST) and Riot Platforms (RIOT).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:THCX
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
C$949.11 million
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (CVE:THCX) was last updated on 5/12/2025 by MarketBeat.com Staff
From Our Partners